Apellis Ushers in a New Era of Geographic Atrophy Treatment with First Ever Approval, According to Spherix Global Insights
Spherix Global Insights surveyed 85 US ophthalmologists, revealing awareness of Apellis’s newly approved GA therapy, Syfovre is high, as are